Hong Kong Electrical Stock News

Autostreets Development stock has barely budged over the past week, yet the H1 print delivered a jolt beneath the surface. The headline is a sharp profit squeeze. Revenue for the half year came in at ¥75.6m while the company swung to a net loss of ¥16.5m and basic earnings per share of ¥0.02 loss. That moves Autostreets from profit in 2025 back into the red. For short term traders the story is about pressure on the income statement. For longer term holders the question is how that squeeze...

Central New Energy Holding Group stock has barely moved over the past month, even as the latest results underline how tight the profit engine has become. The company generated HK$6,329.5m in H1 2026 revenue yet converted only a sliver of that into earnings, with trailing net profit margins sitting at 0.2% and padded by a HK$42.3m one off gain. For short term traders, that kind of margin squeeze can look like noise. For long term holders, it raises hard questions about how much risk is built...

Zhong Ju Investment Group entered this earnings release with a mixed picture. The stock is up roughly 68% over three months, yet is loss-making over the past year and trades on a P/S of 2.3x, well above Hong Kong specialty retail peers. That sets a high bar for any setback in the numbers. The headline today is not revenue; it is profit pressure. Zhong Ju Investment Group posted a half-year loss of ¥21.77 million and a basic loss per share of ¥0.0411. The market now has to decide whether this...

Deep Source Holdings heads into the post earnings session with a share price at HK$0.55 and a trailing P/E of 10.1x, sitting between cheaper peers and a richer Hong Kong trade distributors industry. The real story is sentiment. A stock that has fallen over the past quarter is now facing an earnings print where net profit margin over the last year reached 3.1% and trailing earnings grew sharply. The key question for traders is whether that improvement justifies a re rating or if past multi...

Horizon Robotics walked into this earnings season with a reputation as a high growth, high spend bet on intelligent driving and a stock that has been under pressure, down about 13% over the past three months and closing at HK$4.595 on 1 September. The headline from H1 2026 is not the revenue line; it is the profit squeeze behind it. The company booked about RMB 2.1b in revenue with a rich 66% gross margin, yet still posted an adjusted net loss of roughly RMB 1.67b as heavy research and...

SOHO China stock has drifted lower again, finishing at HK$0.315 after a weak few months, yet the latest half year results point to a different story in the income statement. The headline is not a turnaround. It is that the loss has narrowed sharply while revenue remains in the hundreds of millions of renminbi. For a company long viewed as a chronic loss maker with stretched valuation questions, this half brings a smaller earnings hit and a reminder that the market price still reflects deep...

SR Medical Technology closed at HK$1.665 after the market absorbed another loss making half year. The stock has been weak over the past quarter, and today investors are wrestling with what looks like a tug of war between shrinking losses and a stretched valuation. The headline is simple. Revenue for the first half of 2026 came in at HK$223.138m while the company reported a net loss of HK$70.601m. With a P/S ratio of 14.5x and a market price that sits well above an estimated cash flow value of...

Ruihe Data Technology Holdings has been edging higher in recent weeks, with the stock up about 5.3% over the past three months, yet today’s reaction tells you very little about the real story. The headline in these half year numbers is not revenue; it is the earnings swing back into profit. Basic earnings per share came in at ¥0.0665 and net income reached ¥58.205 million, a sharp contrast with the loss in the previous half. Traders may focus on the short term bounce, but the bigger question...

Jenscare Scientific stock closed at HK$7.42, with the recent 7 day gain of about 5% suggesting that traders welcomed the headline improvement. The headline itself is simple. Losses are shrinking, while the price tag on those losses remains steep. H1 2026 basic earnings per share narrowed to a loss of ¥0.11 and net loss came in at ¥48.69 million. Yet the stock still trades on a P/S ratio of 18.8x, compared with single digit multiples across Hong Kong medical equipment peers. The short term...

Shoucheng Holdings walked into this earnings day with a bruised share price, down over 20% across both one and three months, yet still trading on a P/E of 62.9x and above a discounted cash flow estimate of HK$1.11. The headline this time is margin pressure. Net profit margin for the last 12 months sits at 12.7%, while the prior year was 34.6%, lifted by a one-off HK$178.1m gain. The stock at HK$1.37 now asks investors to decide whether that squeeze reflects temporary noise or a more...

CN Logistics International Holdings walked into this earnings day with a tired share price and a rich earnings multiple. The stock has drifted lower over the past quarter, yet still trades on a trailing P/E of 36x, while many Asian logistics peers sit closer to the low 20s. Against that backdrop, the headline from H1 2026 is simple: revenue reached HK$1,633.7m and basic earnings per share came in at HK$0.089, which leaves a thin 0.8% trailing net margin. The market now has to decide whether...

Hong Kong traders pushed Zhongsheng Group Holdings down to HK$3.93 at Tuesday’s close, extending a rough 90 days for the stock. Yet the latest half year numbers tell a more nuanced story. The company swung from a heavy loss in late 2025 to a modest net profit in the first half of 2026, with basic earnings per share of ¥0.047. The headline is simple: Zhongsheng is still dealing with trailing 12 month losses, but the fresh earnings print hints at a repair job in progress. The key question now...

Superland Group Holdings entered this earnings release with the stock up sharply over the past quarter and closing at HK$4.205, yet the fresh numbers tell a more restrained story. First half 2026 revenue came in at HK$439.79 million with net income of HK$9.875 million, which keeps profits modest relative to the trailing P/E of 120.5x. The market is reacting to a multi month rally colliding with thin margins and a valuation that already prices in a lot of hope. The key issue now is how durable...

China 33 Group closed at HK$2.04 on 1 September, roughly flat over the past week after a weak month. However, the latest half year numbers give a sharper story than the share chart. The stock still trades on a very rich price to sales multiple of 29.2x compared with a Hong Kong media industry average of 0.7x, even though the business remains loss making. The main focus this season is valuation strain. Revenue for the first half of 2026 reached ¥20.24m while the company reported a net loss of...

China Harmony Auto Holding went into this earnings day with a stock that had drifted, down about 2% over the past week and down about 13% over three months, priced at HK$0.635 at the close on 1 September. The market still prices it cheaply on price to sales versus Hong Kong specialty retail peers, yet the fresh H1 2026 numbers underline why the discount exists. Revenue reached ¥12,149.31m in the first half, but the company stayed in the red with a net loss of ¥10.10m and basic earnings per...

Investors came into this Z.AI print watching a stock that had surged 19.4% over the past month yet was still nursing a 19.4% slide over three months. The headline today is not the share price; it is the clash between surging revenue and still heavy losses. First half 2026 revenue reached C¥953.9 million while the company reported a net loss from continuing operations of C¥4.4b over the trailing twelve months. The rest of this earnings read hinges on how long the market is willing to back that...

The market has punished Golden Throat Holdings Group over the past month, with the stock down almost 30% ahead of these results. Yet the latest earnings land a more nuanced blow. H1 2026 net income from core operations came in at ¥47.6 million, and basic earnings per share were ¥0.0644, against a backdrop of already compressed margins over the past year. The real story for you as an investor is not today’s price move; it is the growing strain between a rich 15.25% dividend yield and the...

Black Sesame International Holding shares closed at HK$11.23, roughly flat over the past week after a weak 3 month stretch, even as the latest earnings put the balance sheet in sharper focus. The headline is not revenue for this semiconductor stock. It is the continued heavy losses against a business that, by management’s own data, has less than one year of cash runway. For short term traders that mix can cap enthusiasm. For longer term investors it raises the key question: How will Black...

Investors barely flinched at Mega Genomics on Tuesday, with the stock at HK$7.09 after a flat month and only a small move over the past quarter. The market reaction looks muted compared with the sharp squeeze in profitability that now defines the story. Trailing net profit margin has fallen to 6.8%, while the stock still trades on a P/E of 55.6x, above both healthcare peers and the Hong Kong industry average. If you care about the next few days, that might feel fine. If you care about the...

Radiance Holdings (Group) stock closed at HK$1.135 today, after a choppy few months that left the 90 day return down about 16%. The headline from these H1 2026 numbers is simple. The company moved from heavy losses to a modest profit, with basic earnings per share of ¥0.02 and net income of ¥86.68m on revenue of ¥3,027.39m. That shift in profitability sits against a longer track record of sizeable losses over the past year. For anyone looking beyond today’s price move, the real question now...

C-Link Squared stock closed at HK$0.385 after earnings, leaving short-term traders weighing a recent 7-day decline against solid gains over the past month. The headline is not the share price. It is the pressure embedded in the income statement. Revenue for the latest half year came in at RM66.695 million, yet the company still reported a net loss of RM4.481 million and a loss per share. The key question for longer term holders is whether that loss profile can justify a P/S of 4.1x, given the...

Traders have been willing to pay up for Nanjing Leads Biolabs, with the stock up about 26% over the past month and closing at HK$67.60 before today’s reaction to its half year numbers. The headline from this biotech earnings release is not revenue growth. It is the depth of the ongoing loss, with H1 2026 net income excluding extra items at a loss of C¥221.9 million and basic earnings per share in negative territory again. The question now is whether today’s price move reflects a cool headed...

China Cinda Asset Management stock closed at HK$0.915 on Tuesday, capping a weak run over the past quarter. Yet the real shock sits in the profit line. The latest half year showed revenue of C¥6,513.9m but slipped into a small loss, with basic earnings per share turning to a loss of C¥0.01. For a stock already trading on a rich P/E against peers, this setback in profitability sharpens the focus on whether the balance of risk and reward around China Cinda still stacks up. Is China Cinda Asset...

Xingda International Holdings stock has barely moved over the past week, yet the latest half year numbers tell a more uncomfortable story for anyone banking on a simple value rerating. Revenue in H1 2026 held at roughly ¥5,778m, but net income came in at only ¥65m, which is a sharp step down from recent halves. The real pressure point is profitability. Trailing net margin sits at 1.8%, lower than the prior year, while the P/E near 8.5x suggests a market that already reflects these tighter...